$COCP Shorts covering fast FINRA short interest (4/30 settlement, published today) 586,422 shares down 40.67% from 988k two weeks ago.
English
biotechsmallcap
1K posts
biotechsmallcap
@biotechsmallca1
preclinical stage biotech investor
Katılım Şubat 2021
49 Takip Edilen40 Takipçiler
$COCP New 13F May 8, 2026
Vanguard brand new position
Vanguard Capital: 239,971 sh
Vanguard Trust: 24,016 sh
This is the start of first meaningful new institutional buying seen in years. It’s still a small position for but in $20M mc with a tiny real float, 264k sh is noticeable
English
@ms101phd $COCP this is similar escalation phase map from $GME playbook in 2021 from the GME playbook fees spike hard right before the forced covering starts feeding on itself. If co announced barda boom
English
$COCP update ZERO shares available to borrow
Borrow rate has skyrocketed up 263% 2.21 to 8.39
biotechsmallcap@biotechsmallca1
$COCP Zero shares available for borrow!
English
biotechsmallcap retweetledi
$COCP Receives FDA Fast Track Designation for CDI-988 for Norovirus Infection Treatment and Preventive
English
@ms101phd @hVIVO_UK @CocrystalPharma $COCP the PR link - @hVIVO_UK $MRK @CocrystalPharma pharmatimes.com/news/msd-to-ac…
English
@ms101phd @hVIVO_UK $COCP @hVIVO_UK 42344 flu challenge you ran that was a total mess (low placebo shedding = inconclusive, program deprioritized). Selective PR game strong. Cherry-picking wins only? Time the CRO is exposed and if viral bad look @CocrystalPharma
English
$COCP @hVIVO_UK has 20+ years running these exact studies, developed their own flu challenge strains, operates the specialized UK quarantine facilities, and markets itself everywhere as “the world leader in conducting human challenge trials in infectious and respiratory diseases” with the most used commercial influenza models on the mkt. The study suffered from operational failures (the low infection rate 100% CRO responsibility). Either pay $6.3 million refund or a full redo.
ms101phd@ms101phd
$COCP so a full refund or free redo would be a material non-dilutive win that directly strengthens the influenza program runway and de-risks the new Phase 2a restart. The company is taking a strong, aggressive position by formally claiming breach and preparing for arbitration classic quiet board-level execution.
English
$COCP Stock held down but norovirus tailwinds are massive! Goldman new market maker!
English
$COCP Form 4, New insider buy billionaire Phillip Frost 20K shares. This brings his total open market purchases since November 2025 to 229,000 shares. His cumulative beneficial ownership (indirect through Frost Gamma Investments Trust) after this transaction is 1,908,551 shares
English
$COCP new form 4- new insider buy 50,000 shares Phillip Frost. Mutli billionaire added 259,000 in open mkt since November 2025.
English
$COCP Martin: "Fred Hassan quietly building another M&A empire with norovirus as gov funds are near" #Biotech
Water Tower Research LLC@WTR_Research
On the latest WTR Healthcare Happenings Podcast, Tim Gerdeman and Robert Sassoon speak with James J. Martin, CPA, Co-CEO and CFO of Cocrystal Pharma, Inc. (NASDAQ: $COCP), about the company’s clinical-stage antiviral opportunity. Listen to the full episode to learn more about CDI-988, upcoming catalysts, and Cocrystal’s broader antiviral strategy. Podcast Platforms: pod.link/1795488592 Website: watertowerresearch.com/media-detail/3… $COCP #CocrystalPharma #Norovirus #AntiviralTherapies #Biotech #ClinicalTrials #HealthcareInnovation #InfectiousDisease #DrugDiscovery #SmallCaps #HealthcareHappenings #WaterTowerResearch @CocrystalPharma
English
biotechsmallcap retweetledi
biotechsmallcap retweetledi
biotechsmallcap retweetledi
Nobody cares about this $PGEN monthly chart. Still. Somehow.
English
$COCP The market yawns that's almost 200k shares in open market at rock-bottom prices for multi billionaire Philip Frost right before the 2026 catalyst storm for norovirus barda funding news that's when the world will care and the regret will be epic
Average Insider@AvgInsider
🚨 Insider Alert: $COCP (Cocrystal Pharma, Inc) Director PHILLIP MD ET AL FROST buys 50,000 shares at $0.95 ($47,275.00 total) on Dec 31, 2025. 💰 P&L: +5.0% (+$2,365) Price: $0.99 52W: $0.90 (5.2% above)-$2.67 (94.8% below) averageinsider.com/filings/19928
English
biotechsmallcap retweetledi
Scientists are baffled over the sudden surge of the rib-cracking winter virus.
“The two possibilities is that something in the virus changed to make it more transmissible, or there were changes in the population that a larger proportion were susceptible.”
dailymail.co.uk/health/article…
English